Company Overview and News

2
Yamana Gold Announces Creation of Executive Chairman Role and Appointment of New President and Chief Executive Officer

2018-08-08 globenewswire
TORONTO, Ontario, Aug. 08, 2018 (GLOBE NEWSWIRE) -- YAMANA GOLD INC. (TSX:YRI; NYSE:AUY) (“Yamana” or “the Company”) is pleased to announce the promotion of Daniel Racine to President and Chief Executive Officer (“CEO”), from his current role as Executive Vice President, Chief Operating Officer. Peter Marrone, the Company’s Chairman and CEO, is assuming a newly created role as Executive Chairman, and will continue to serve as Chairman of Yamana’s Board of Directors.
AUY YRI MALRY MALRF MIN

6
Buy These Gold Stocks As Gold Futures Set 2018 Lows

2018-08-03 seekingalpha
The Comex gold futures contract has a negative weekly chart but should be bought at my quarterly value level at $1,205.9.
ABX AUY NEM YRI GG ABX

12
Sandstorm Gold's (SAND) CEO Nolan Watson on Q1 2018 Results - Earnings Call Transcript

2018-08-02 seekingalpha - 3
Good morning. My name is Leonie, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Sandstorm Gold Limited Second Quarter Results Conference Call. All lines have been placed on mute to prevent any background noise.
ICG RIO RIO YRI MEAOF NXXGD BTR ICGQF RTPPF MUX.RTWI NXXGF AUY EDVVF RTNTF MUX EDV WPM SAND SSL SDDXF MUX NXS EDVMF SNXZF RGLD RIO EVR RGL

29
Top Analyst Upgrades and Downgrades: Akamai, Apple, AutoZone, Dropbox, EA, Ford, Kinder Morgan, Pandora, P&G, Shopify and More

2018-08-01 247wallst - 1
The major equity indexes were looking for direction on Wednesday morning ahead of the Federal Reserve’s decision on interest rates. Earnings season is still going strong, with dozens of household company names reporting earnings each day. Investors have had less success buying the all the stock market dips in 2018 than in prior years. Many investors are also reconsidering how they want their investments positioned ahead of the midterm elections and with international trade concerns.
DB PG YRI AZO NOC DBX KMI AUY CSU AAPL MS KMR CVB AKAM VNTR EA F SHOP P SRPT UHS UHID TRI JHG KMRFZ PZZA

9
Gold Mining Bull: Top News For July 2018

2018-07-31 seekingalpha - 2
Detour Gold battles with an activist investor; former Alexandria CEO fails to regain control of company.
WPM NGD LUNMF NEM YRI CPNFD NGDAF LUNCF DRGDF NGD LUN EQXGF ORE NSU ORZCF AUY DGC GG HTXFF

2
Yamana Gold Second-Quarter 2018 Results Analysis

2018-07-31 seekingalpha
Free cash flow is expected to turn finally positive next quarter after the completion of the Cerro Moro. It is the most important takeaway from the second quarter.
AUY YRI BRRGF

48
Top Analyst Upgrades and Downgrades: Athenahealth, Illumina, Northrop Grumman, Square, Twitter, Yamana Gold and More

2018-07-31 247wallst - 1
Stocks were indicated to open marginally higher on Tuesday morning after a larger sell-off on Monday. Investors have been having less success buying the stock market dips in 2018 than in prior years. Many investors also are reconsidering how they want their investments positioned ahead of the midterm elections and during international trade concerns.
NTRI DB SQNXF YRI CHKVP NOV ILMN CHKDH CHKVZ CHKDG NOC TJX CHKDJ CHKDP AUY TWTR CKRGZ SQ BMRN CHKWZ ALLY CHK.WI CHK TRI ATHN

3
Yamana Gold Celebrates Its 15th Anniversary

2018-07-31 globenewswire - 1
TORONTO, July 31, 2018 (GLOBE NEWSWIRE) -- YAMANA GOLD INC. (TSX:YRI; NYSE:AUY) (“Yamana” or “the Company”) is pleased to announce it is celebrating its 15th anniversary today. On this day in 2003, the Company was taken public with an initial portfolio that included the Chapada project in Brazil, which it subsequently developed and brought into production in 2007.
AUY YRI MALRY MALRF MIN

2
Abitibi Royalties: Update on Canadian Malartic Mine Royalties

2018-07-30 globenewswire
VAL-D’OR, Québec, July 30, 2018 (GLOBE NEWSWIRE) -- Abitibi Royalties Inc. (TSX-V:RZZ) (OTC-Nasdaq Intl:ATBYF) (“Abitibi Royalties” or the “Company”) is pleased to provide an update on the Company’s net smelter royalties (“NSR”) at the Canadian Malartic Mine, Canada’s largest gold mine, near Val-d’Or, Québec.
AUY YRI AEM ATBYF RZZ

4
Yamana Gold shares shine as miner says it's on track to beat production guidance for full year

2018-07-27 proactiveinvestors.com.au - 2
Improved operational performance at South America-focused gold miner Yamana Gold Inc (TSX: YRI, NYSE: AUY) is starting to take hold as the group posted solid second quarter results and revealed it was on track to beat previous production guidance for the year.
YRI AUY

3
Yamana Gold Inc. (AUY) CEO Peter Marrone on Q2 2018 Results - Earnings Call Transcript

2018-07-27 seekingalpha - 1
Thank you all for joining us this morning. Before I turn the call over, I need to advise that certain statements made during this call today may contain forward-looking information and actual results could differ from the conclusions or projections in that forward-looking information, which include, but are not limited to, statements with respect to the estimation of mineral reserves and resources, the timing and amount of estimated future production, cost of production, capital expenditures, future metal prices, and the cost and timing of the development of new projects.
AUY YRI

6
Yamana Gold's (AUY) Q2 Earnings Beat, Revenues Rise Y/Y

2018-07-27 zacks - 1
Yamana Gold Inc. (AUY - Free Report) reported net earnings (attributable to equity holders) of $18 million or 2 cents per share in second-quarter 2018, against a net loss of $39.9 million or 4 cents in the prior-year quarter. Barring one-time items, adjusted earnings came in at 6 cents per share, which beat the Zacks Consensus Estimate of 2 cents. Revenues inched up roughly 0.8% year over year to $431.
EA BLT YRI BHPBF BHP AUY KMG BBL BHP NVR TRN BHPLF MEOH

4
Deutsche Bank's (DB) Q2 Earnings Decline Y/Y, Costs Increase

2018-07-25 zacks
Deutsche Bank AG (DB - Free Report) reported net income of €401 million ($467 million) in second-quarter 2018, which tanked 13.7% from year-ago quarter. Income before income taxes plunged 13.5% year over year to €711 million ($828.1 million).
DB YRI 55BC BOH CBQS UBS AUY MS ULSGF

11
CIT Group (CIT) Up 1% on Q2 Earnings Beat, Provisions Surge

2018-07-25 zacks - 1
Shares of CIT Group Inc. (CIT - Free Report) gained nearly 1% following the release of its second-quarter 2018 results. Adjusted earnings from continuing operations of $1.00 per share surpassed the Zacks Consensus Estimate of 97 cents. Also, this was above the prior-year quarter’s figure of 68 cents.
LC YRI SYF AUY MS CIT

3
Navient (NAVI) Q2 Earnings Beat Estimates, Provisions Fall

2018-07-25 zacks
Navient Corporation’s (NAVI - Free Report) second-quarter 2018 adjusted core earnings per share (EPS) of 49 cents surpassed the Zacks Consensus Estimate by a penny. The reported figure came in higher than the year-ago quarter tally of 43 cents.
YRI PBCT CFG CFIN NAVI CIWV AUY MS

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...